Cargando…
Thymosin α1 protects from CTLA-4 intestinal immunopathology
The advent of immune checkpoint inhibitors has represented a major boost in cancer therapy, but safety concerns are increasingly being recognized. Indeed, although beneficial at the tumor site, unlocking a safeguard mechanism of the immune response may trigger autoimmune-like effects at the peripher...
Autores principales: | Renga, Giorgia, Bellet, Marina M, Pariano, Marilena, Gargaro, Marco, Stincardini, Claudia, D’Onofrio, Fiorella, Mosci, Paolo, Brancorsini, Stefano, Bartoli, Andrea, Goldstein, Allan L, Garaci, Enrico, Romani, Luigina, Costantini, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441522/ https://www.ncbi.nlm.nih.gov/pubmed/32817121 http://dx.doi.org/10.26508/lsa.202000662 |
Ejemplares similares
-
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023) -
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
por: Costantini, Claudio, et al.
Publicado: (2019) -
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease
por: Renga, Giorgia, et al.
Publicado: (2019) -
Microbes in the Era of Circadian Medicine
por: Costantini, Claudio, et al.
Publicado: (2020) -
Indole-3-Carboxaldehyde Restores Gut Mucosal Integrity and Protects from Liver Fibrosis in Murine Sclerosing Cholangitis
por: D’Onofrio, Fiorella, et al.
Publicado: (2021)